Home/Filings/4/0001343238-10-000016
4//SEC Filing

GROUP VI 31 LLC 4

Accession 0001343238-10-000016

CIK 0001472595other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 6:10 PM ET

Size

18.5 KB

Accession

0001343238-10-000016

Insider Transaction Report

Form 4
Period: 2010-05-25
Transactions
  • Conversion

    Common Stock

    2010-05-25+1,477,16117,424,762 total
  • Other

    Common Stock

    2010-05-25+502,69617,097,972 total
  • Conversion

    Series A Convertible Preferred Stock

    2010-05-2513,2730 total
    Common Stock (15,947,601 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2010-05-25376,8270 total
    Common Stock (1,477,161 underlying)
  • Conversion

    Common Stock

    2010-05-25+15,947,60115,947,601 total
  • Sale

    Common Stock

    2010-05-25$11.28/sh829,486$9,356,60216,595,276 total
Transactions
  • Sale

    Common Stock

    2010-05-25$11.28/sh829,486$9,356,60216,595,276 total
  • Conversion

    Common Stock

    2010-05-25+1,477,16117,424,762 total
  • Conversion

    Common Stock

    2010-05-25+15,947,60115,947,601 total
  • Other

    Common Stock

    2010-05-25+502,69617,097,972 total
  • Conversion

    Series A Convertible Preferred Stock

    2010-05-2513,2730 total
    Common Stock (15,947,601 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2010-05-25376,8270 total
    Common Stock (1,477,161 underlying)
Transactions
  • Conversion

    Common Stock

    2010-05-25+15,947,60115,947,601 total
  • Sale

    Common Stock

    2010-05-25$11.28/sh829,486$9,356,60216,595,276 total
  • Other

    Common Stock

    2010-05-25+502,69617,097,972 total
  • Conversion

    Series D Convertible Preferred Stock

    2010-05-25376,8270 total
    Common Stock (1,477,161 underlying)
  • Conversion

    Common Stock

    2010-05-25+1,477,16117,424,762 total
  • Conversion

    Series A Convertible Preferred Stock

    2010-05-2513,2730 total
    Common Stock (15,947,601 underlying)
Footnotes (4)
  • [F1]The Series A Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1,201.5069 for one basis and had no expiration date.
  • [F2]The Series D Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 3.92 for one basis and had no expiration date.
  • [F3]FW Oak Hill Accretive Healthcare Investors, L.P. (the "Oak Hill Partnership") elected to receive shares of common stock, based on the initial public offering price of $12.00 per share, in satisfaction of the liquidation preference payment payable to the holders of the Issuer's preferred stock upon the closing of its initial public offering.
  • [F4]Group VI 31, LLC ("Group VI 31") is the sole general partner of the Oak Hill Partnership, which is the direct holder of the shares reported herein. J. Taylor Crandall ("Crandall") is the sole member and President of Group VI 31 and a limited parter of the Oak Hill Partnership. Crandall and Group VI 31 disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

Issuer

Accretive Health, Inc.

CIK 0001472595

Entity typeother

Related Parties

1
  • filerCIK 0001247520

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 6:10 PM ET
Size
18.5 KB